Skip to main content

and
  1. Article

    Open Access

    Clinical value of R-spondins in triple-negative and metaplastic breast cancers

    RSPO ligands, activators of the Wnt/β-catenin pathway, are overexpressed in different cancers. The objective of this study was to investigate the role of RSPOs in breast cancer (BC).

    F Coussy, F Lallemand, S Vacher, A Schnitzler, W Chemlali in British Journal of Cancer (2017)

  2. Article

    Open Access

    Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen

    Triple-negative (TN) breast cancers exhibit major initial responses to neoadjuvant chemotherapy, but generally have a poor outcome. Because of the lack of validated drug targets, chemotherapy remains an import...

    S Giacchetti, R Porcher, J Lehmann-Che, A-S Hamy in British Journal of Cancer (2014)

  3. Article

    Open Access

    HER2-overexpressing breast cancer: FDG uptake after two cycles of chemotherapy predicts the outcome of neoadjuvant treatment

    Pathologic complete response (pCR) to neoadjuvant treatment (NAT) is associated with improved survival of patients with HER2+ breast cancer. We investigated the ability of interim positron emission tomography ...

    D Groheux, S Giacchetti, M Hatt, M Marty, L Vercellino in British Journal of Cancer (2013)